Compare RLX Technology Inc (RLX) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
RLX Technology Inc vs Revolution Medicines Inc. Common Stock — how do they compare? RLX Technology Inc trades at $1.73 (market cap $2.10B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 19.2× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.81% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold RLX Technology Inc for 35 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| RLX | RVMD | |
|---|---|---|
Market Cap | $2.10B | $40.32B |
Volume | 1,079,706 | 4,855,734 |
Sector | Consumer Staples | Health |
52-Week High | $2.57 | $221.15 |
52-Week Low | $1.68 | $47.50 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $832.26M | $37.02B |
Dividend Yield | 5.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RLX trades at $1.73, unchanged on the day, and has recently set new 52-week lows. The technical outlook is bearish, with moving averages signaling selling pressure. Fundamentally, the company reported $3.62B in 2025 revenue and $921.87M net income, though recent quarters show earnings misses against expectations. International expansion, now 70% of revenue, drives growth, but margin compression is a concern. Analyst coverage is limited, with a single hold rating indicating caution.
The outlook is mixed; strong international growth and a discounted valuation (P/E 15.46, P/B 0.91) offer potential upside, but persistent earnings misses, bearish technicals, and regulatory risks in the e-vapor industry pose significant headwinds. Investor sentiment remains neutral to cautious amid recent price weakness.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
